Tech

Why creators are ditching ad revenue for chocolate bars and fintech acquisitions

Equity unpacks how creators are diversifying beyond ads, whether their model can scale beyond the top 1%, everything happening at India's AI Impact Summit, and more of the week's headlines.

Samsung brings a generative AI-powered Bixby to its TVs

Posts from this topic will be added to your daily email digest and your homepage feed.

Xslop?

Xbox shakeup: Phil Spencer and Sarah Bond are leaving Microsoft

Read Microsoft gaming CEO Asha Sharma’s first memo on the future of Xbox

Posts from this topic will be added to your daily email digest and your homepage feed.

Xbox chief Phil Spencer is leaving Microsoft

Posts from this topic will be added to your daily email digest and your homepage feed.

InScope nabs $14.5M to solve the pain of financial reporting

The startup, founded by accountants who worked at Flexport, Miro, Hopin and Thrive Global, automates the difficulties of prepping financial statements.

Wikipedia blacklists Archive.today, starts removing 695,000 archive links

If DDoSing a blog wasn’t bad enough, archive site also tampered with web snapshots.

Great news for xAI: Grok is now pretty good at answering questions about Baldur’s Gate

A new report from Business Insider reveals that high-level engineers at xAI were pulled off other projects to make sure Grok could answer detailed questions about the video game "Baldur's Gate."

People Moves: Lucius DiPhillips, CIO at Adobe

Lucius DiPhillips is set to lead Adobe’s global Technology Services team, supporting the company's growth as a leader in AI-powered creativity

Amazon blames human employees for an AI coding agent's mistake

Posts from this topic will be added to your daily email digest and your homepage feed.

OpenAI’s first ChatGPT gadget could be a smart speaker with a camera

Posts from this topic will be added to your daily email digest and your homepage feed.

All About the UK’s £1.6bn Vision for Healthcare AI

AI strategy investment by the UK government, worth £1.6bn (US$2.2bn), aims to boost healthcare innovation from early disease detection to drug discovery